Glufovi Tablet 10/100 mg
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
MFDS item code 202200495 · Approved 2022.01.28
Improvement of blood sugar control in type 2 diabetes
This medication is used in conjunction with diet and exercise to help patients with type 2 diabetes control their blood sugar. The combination of sitagliptin and dapagliflozin enhances blood sugar control, helping to improve management of blood sugar levels more effectively. It is used to improve blood sugar control through consistent usage and lifestyle modifications.
For patients receiving sitagliptin 100 mg and dapagliflozin 10 mg, administer 1 tablet once daily, regardless of meals. The tablet should be swallowed whole.
This medication may cause severe allergic reactions. If symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a doctor. This medication may cause a serious pancreatic inflammation called pancreatitis, so if sudden abdominal pain, nausea, or vomiting occurs, seek medical attention right away. Patients with allergies to any components or additives of this drug, individuals with type 1 diabetes, certain hereditary lactose intolerance, and those undergoing dialysis should not take this medication. Patients with impaired kidney function or decreased fluid volume should consult with a doctor before taking this medication, and blood pressure and kidney function should be monitored periodically during use. This medication can increase the risk of genital infections and urinary tract infections, so immediate treatment should be sought if infection symptoms appear. Due to the risk of hypoglycemia, especially when used alongside insulin or sulfonylureas, blood sugar levels should be checked frequently, and medication dosages may need adjustment as necessary. Women who are pregnant or planning to become pregnant should avoid using this medication, and it is also recommended that breastfeeding women do not use this medication. Safety and efficacy in children and adolescents under 18 have not been established, and use in these populations is not recommended. In elderly patients, kidney function may decline, so kidney function testing is needed before and during treatment. In case of overdose, there is no specific antidote, so appropriate treatment should be given based on symptoms, and blood dialysis may be considered if necessary. This medication does not significantly affect driving or operating machinery, but caution is advised due to the potential for hypoglycemic symptoms.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attack, respiratory distress with coughing and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, lightning-like headache, seizures, altered consciousness, visual disturbances, paralysis, urination changes
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 and 30 degrees Celsius.
Yellow, rectangular film-coated tablet
28 tablets/box [(7 tablets/Blister x 4)], 30 tablets/box [(10 tablets/Blister x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.